Buscar resultados de ensayos clínicos
Nephrotic Syndrome - 28 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome:a Prospective Observational Study Condición: Nephrotic Syndrome,Idiopathic Fecha: 2014-10-20 Intervenciones: Drug: prednisone Full-dose induction period: Prednisone 1mg/kg.day, maximum 60mg/day, orally, divided in |
Completed |
Nombre del estudio: Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) Condición: Treatment Resistant Nephrotic Syndrome Fecha: 2010-05-21 Intervenciones: Drug: ACTHAR gel Patients will be treated with ACTHAR gel starting with 40 units given twice weekly subc |
Completed |
Nombre del estudio: Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome Condición: Idiopathic Nephrotic Syndrome Fecha: 2012-04-25 Intervenciones: Genetic: DNA chip dedicated to the pharmacogenetic of steroids direct DNA extraction from peripheral blo |
Recruiting |
Nombre del estudio: Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome Condición: Nephrotic Syndrome Fecha: 2016-12-16 Intervenciones:
|
Recruiting |
Nombre del estudio: Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome Condición: Nephrotic Syndrome Fecha: 2015-03-06 Intervenciones:
|
NOT_YET_RECRUITING |
Nombre del estudio: Effectiveness of Educational Gamified Cards About Nephrotic Syndrome Condición: Fecha: 2024-05-19 Intervenciones:
|
NOT_YET_RECRUITING |
Nombre del estudio: Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome Condición: Nephrotic Syndrome Fecha: 2024-05-19 Intervenciones: ADX-629 (250 milligrams) administered twice daily |
RECRUITING |
Nombre del estudio: A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome Condición: Childhood Idiopathic Nephrotic Syndrome Fecha: 2024-05-19 Intervenciones: Obinutuzumab will be administered as per schedule specified in the respective arm. |